Robert F. Sidonio

3.6k total citations · 2 hit papers
129 papers, 2.1k citations indexed

About

Robert F. Sidonio is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Robert F. Sidonio has authored 129 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Hematology, 33 papers in Genetics and 13 papers in Surgery. Recurrent topics in Robert F. Sidonio's work include Hemophilia Treatment and Research (78 papers), Platelet Disorders and Treatments (57 papers) and Blood Coagulation and Thrombosis Mechanisms (21 papers). Robert F. Sidonio is often cited by papers focused on Hemophilia Treatment and Research (78 papers), Platelet Disorders and Treatments (57 papers) and Blood Coagulation and Thrombosis Mechanisms (21 papers). Robert F. Sidonio collaborates with scholars based in United States, Canada and Italy. Robert F. Sidonio's co-authors include Michael R. DeBaun, Johnny Mahlangu, Michael U. Callaghan, Midori Shima, Johannes Oldenburg, Guy Young, Tiffany Chang, Marianne Uguen, Christophe Schmitt and Ri Liesner and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Robert F. Sidonio

117 papers receiving 2.0k citations

Hit Papers

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von ... 2019 2026 2021 2023 2021 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease
    2021 285 citations Paula James, Barbara A. Konkle et al. Blood Advances profile →
  2. A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
    2019 263 citations Guy Young, Tiffany Chang et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert F. Sidonio United States 22 1.7k 453 196 181 172 129 2.1k
P.M. Mannucci Italy 24 1.4k 0.8× 335 0.7× 164 0.8× 200 1.1× 261 1.5× 53 1.9k
W. Schramm Germany 21 1.5k 0.9× 327 0.7× 222 1.1× 118 0.7× 234 1.4× 67 1.9k
Massimo Franchini Italy 18 771 0.5× 203 0.4× 99 0.5× 153 0.8× 77 0.4× 40 1.1k
Cristina Santoro Italy 21 1.2k 0.7× 501 1.1× 245 1.3× 76 0.4× 116 0.7× 106 1.5k
Marina Panova‐Noeva Germany 19 365 0.2× 268 0.6× 215 1.1× 342 1.9× 178 1.0× 63 1.3k
Dora Bachir France 23 1.1k 0.7× 1.3k 3.0× 151 0.8× 92 0.5× 82 0.5× 45 1.7k
Michelle Lavin Ireland 17 839 0.5× 206 0.5× 68 0.3× 131 0.7× 191 1.1× 63 1.1k
Saskia E.M. Schols Netherlands 19 676 0.4× 159 0.4× 62 0.3× 109 0.6× 104 0.6× 77 1.0k
Donald L. Yee United States 20 555 0.3× 96 0.2× 47 0.2× 383 2.1× 190 1.1× 56 1000
Rochelle Winikoff Canada 14 567 0.3× 200 0.4× 43 0.2× 64 0.4× 92 0.5× 28 985

Countries citing papers authored by Robert F. Sidonio

Since Specialization
Citations

This map shows the geographic impact of Robert F. Sidonio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert F. Sidonio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert F. Sidonio more than expected).

Fields of papers citing papers by Robert F. Sidonio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert F. Sidonio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert F. Sidonio. The network helps show where Robert F. Sidonio may publish in the future.

Co-authorship network of co-authors of Robert F. Sidonio

This figure shows the co-authorship network connecting the top 25 collaborators of Robert F. Sidonio. A scholar is included among the top collaborators of Robert F. Sidonio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert F. Sidonio. Robert F. Sidonio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sidonio, Robert F., et al.. (2025). Factor VIII and von Willebrand factor activity levels during long-term prophylaxis with wilate—Analyses from the WIL-31 study. Research and Practice in Thrombosis and Haemostasis. 10(1). 103327–103327.
3.
Goldenberg, Neil A., Sam Schulman, John M. Kittelson, et al.. (2024). Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years. Journal of Thrombosis and Haemostasis. 23(2). 651–656.
4.
Agarwal, Suresh, Cédric Hermans, Wolfgang Miesbach, et al.. (2024). Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A. Haemophilia. 30(4). 905–913.
5.
Sidonio, Robert F., Ana Boban, Adlette Inati, et al.. (2024). von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease. Blood Advances. 8(6). 1405–1414. 10 indexed citations
6.
Batsuli, Glaivy, Suchitra Acharya, Osman Khan, et al.. (2024). Real‐world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi‐institutional case series. Haemophilia. 30(6). 1321–1331. 1 indexed citations
7.
Wynn, Tung, et al.. (2024). Development of a Working Definition of Severe Von Willebrand Disease. Blood. 144(Supplement 1). 5019–5019. 1 indexed citations
8.
Sholzberg, Michelle, Angela C. Weyand, Benjamin Kim, et al.. (2024). Diagnosis and Disease Burden of Von Willebrand Disease in a Large US Population Based-Dataset. Blood. 144(Supplement 1). 3980–3980.
9.
10.
O’Sullivan, Jamie M., Michael Makris, Augusto B. Federici, et al.. (2023). Von Willebrand Disease: Gaining a global perspective. Haemophilia. 29(4). 1104–1112. 8 indexed citations
11.
Sidonio, Robert F., Christine Knoll, Flora Peyvandi, et al.. (2021). Immunogenicity, Efficacy and Safety of Rurioctocog Alfa Pegol in Previously Untreated Patients with Severe Hemophilia a: Interim Results from an Open-Label Multicenter Clinical Trial. Blood. 138(Supplement 1). 3184–3184. 3 indexed citations
12.
Roberts, Jonathan, Roshni Kulkarni, Peter A. Kouides, et al.. (2021). Depression and Anxiety in Persons with Von Willebrand Disease. Blood. 138(Supplement 1). 4052–4052. 4 indexed citations
13.
Galen, Karin P. M. van, Roseline d’Oiron, Paula James, et al.. (2021). A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 19(8). 1883–1887. 91 indexed citations
14.
Mancuso, Maria Elisa, Johnny Mahlangu, Robert F. Sidonio, et al.. (2020). Health‐related quality of life and caregiver burden of emicizumab in children with haemophilia A and factor VIII inhibitors—Results from the HAVEN 2 study. Haemophilia. 26(6). 1009–1018. 18 indexed citations
15.
Jaffray, Julie, Janice M. Staber, Jemily Malvar, et al.. (2020). Laboratory misdiagnosis of von Willebrand disease in post‐menarchal females: A multi‐center study. American Journal of Hematology. 95(9). 1022–1029. 16 indexed citations
16.
Malec, Lynn, Dunlei Cheng, Char Witmer, et al.. (2020). The impact of extended half‐life factor concentrates on prophylaxis for severe hemophilia in the United States. American Journal of Hematology. 95(8). 960–965. 22 indexed citations
17.
Buckner, Tyler W., Robert F. Sidonio, Michelle Witkop, et al.. (2019). <p>Correlations between patient-reported outcomes and self-reported characteristics in adults with hemophilia B and caregivers of children with hemophilia B: analysis of the B-HERO-S study</p>. Patient Related Outcome Measures. Volume 10. 299–314. 4 indexed citations
18.
19.
Sidonio, Robert F., et al.. (2015). New developments in pediatric venous thromboembolism and anticoagulation, including the target-specific oral anticoagulants. Current Opinion in Pediatrics. 27(1). 18–25. 10 indexed citations
20.
Warren, Michael D., Angela M. Miller, Robert F. Sidonio, et al.. (2013). Late Vitamin K Deficiency Bleeding in Infants Whose Parents Declined Vitamin K Prophylaxis â Tennessee, 2013. PubMed Central. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P.M. Mannucci Breakdown of academic impact, for papers by W. Schramm Breakdown of academic impact, for papers by Massimo Franchini Breakdown of academic impact, for papers by Cristina Santoro Breakdown of academic impact, for papers by Marina Panova‐Noeva Breakdown of academic impact, for papers by Dora Bachir Breakdown of academic impact, for papers by Michelle Lavin Breakdown of academic impact, for papers by Saskia E.M. Schols Breakdown of academic impact, for papers by Donald L. Yee Breakdown of academic impact, for papers by Rochelle Winikoff
Rankless by CCL
2026